KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,190,000 | -39.7% | 350,000 | -33.4% | 0.00% | – |
| Q2 2018 | $1,975,000 | -6.5% | 525,199 | +1.7% | 0.00% | – |
| Q1 2018 | $2,113,000 | -41.2% | 516,600 | -33.1% | 0.00% | -100.0% |
| Q4 2017 | $3,593,000 | -27.8% | 772,685 | +10.2% | 0.00% | -50.0% |
| Q3 2017 | $4,979,000 | -29.8% | 701,206 | -28.6% | 0.00% | -50.0% |
| Q2 2017 | $7,097,000 | +0.2% | 981,608 | -14.6% | 0.00% | 0.0% |
| Q1 2017 | $7,080,000 | +26.9% | 1,149,275 | +20.7% | 0.00% | +100.0% |
| Q4 2016 | $5,578,000 | +15.0% | 951,956 | +4.2% | 0.00% | 0.0% |
| Q3 2016 | $4,850,000 | -9.2% | 913,222 | +13.2% | 0.00% | -33.3% |
| Q2 2016 | $5,341,000 | +12.6% | 806,867 | -20.5% | 0.00% | 0.0% |
| Q1 2016 | $4,742,000 | -1.6% | 1,015,352 | +6.4% | 0.00% | 0.0% |
| Q4 2015 | $4,820,000 | +54.7% | 954,393 | +7.9% | 0.00% | +200.0% |
| Q3 2015 | $3,115,000 | -71.5% | 884,882 | -19.2% | 0.00% | -75.0% |
| Q2 2015 | $10,931,000 | -9.8% | 1,095,252 | +15.1% | 0.00% | -20.0% |
| Q1 2015 | $12,118,000 | -21.6% | 951,870 | -12.8% | 0.01% | -28.6% |
| Q4 2014 | $15,451,000 | -39.3% | 1,091,948 | -41.0% | 0.01% | -30.0% |
| Q3 2014 | $25,446,000 | +15.9% | 1,850,631 | +29.7% | 0.01% | 0.0% |
| Q2 2014 | $21,951,000 | +2.0% | 1,427,288 | +13.0% | 0.01% | 0.0% |
| Q1 2014 | $21,531,000 | -18.3% | 1,263,510 | -37.9% | 0.01% | -9.1% |
| Q4 2013 | $26,362,000 | +38.1% | 2,035,680 | +7.7% | 0.01% | 0.0% |
| Q3 2013 | $19,084,000 | +118.3% | 1,889,487 | +61.4% | 0.01% | +120.0% |
| Q2 2013 | $8,742,000 | – | 1,170,410 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |